Biren Amin
Stock Analyst at Piper Sandler
(2.60)
# 2,962
Out of 5,081 analysts
661
Total ratings
40.2%
Success rate
0.9%
Average return
Main Sectors:
Stocks Rated by Biren Amin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBOT BridgeBio Oncology Therapeutics | Reiterated: Buy | $21 | $2.64 | +695.45% | 11 | Oct 26, 2026 | |
| CBIO Crescent Biopharma | Reiterated: Buy | $35 | $12.76 | +174.29% | 26 | Oct 26, 2026 | |
| CMPX Compass Therapeutics | Reiterated: Buy | $6 | $0.7472 | +703.00% | 9 | Oct 26, 2026 | |
| ACRS Aclaris Therapeutics | Reiterated: Buy | $11 | $3.79 | +190.24% | 9 | Oct 19, 2026 | |
| BBIO BridgeBio Pharma | Reiterated: Buy | $115 → $120 | $68.15 | +76.08% | 36 | Oct 19, 2026 | |
| LENZ LENZ Therapeutics | Reiterated: Hold | $7 → $5 | $3.15 | +58.98% | 11 | Oct 19, 2026 | |
| REGN Regeneron Pharmaceuticals | Reiterated: Buy | $854 → $865 | $807.67 | +7.10% | 48 | Oct 19, 2026 | |
| SRPT Sarepta Therapeutics | Reiterated: Hold | $20 | $17.98 | +11.23% | 29 | Oct 19, 2026 | |
| IRD Opus Genetics | Reiterated: Buy | $11 | $3.32 | +231.33% | 5 | Oct 16, 2026 | |
| TSHA Taysha Gene Therapies | Reiterated: Buy | $12 | $4.01 | +199.25% | 12 | Oct 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $35 | $25.55 | +36.99% | 11 | Oct 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 | $6.47 | +379.13% | 29 | Oct 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $5.81 | +209.81% | 17 | Sep 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $101 → $123 | $70.54 | +74.37% | 10 | Sep 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $140 | $114.84 | +21.91% | 4 | Sep 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $1.44 | +386.11% | 3 | Aug 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.21 | +726.45% | 23 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $0.8489 | +724.60% | 2 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $17.89 | +84.46% | 16 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $2 | $0.5054 | +295.73% | 1 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 → $14 | $1.21 | +1,057.02% | 9 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $71 | $24.21 | +193.27% | 14 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $0.2399 | +2,817.88% | 8 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $15.45 | +210.68% | 8 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 → $7 | $1.80 | +288.89% | 3 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $51 | $3.99 | n/a | 4 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $10 → $0.7 | - | n/a | 5 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $63 → $70 | $2.07 | n/a | 4 | May 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $142 → $94 | $145.87 | n/a | 44 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $56 | $20.39 | n/a | 4 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $0.3007 | n/a | 20 | Jul 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $19 | $7.15 | n/a | 2 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $8 → $7 | $6.16 | n/a | 11 | Mar 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 → $51 | $2.98 | n/a | 2 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 | $1.25 | n/a | 5 | Feb 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $32 | $3.65 | n/a | 2 | Jan 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $39 → $109 | $2.06 | n/a | 3 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $43 → $60 | $13.78 | n/a | 18 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.53 | n/a | 3 | Dec 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $15 → $10 | $0.1862 | n/a | 2 | Sep 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $9 | $2.23 | n/a | 12 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $36 → $18 | $44.44 | n/a | 32 | Jul 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $41 | $59.97 | n/a | 1 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $18 → $2 | $2.20 | n/a | 4 | May 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $0.0003 | n/a | 1 | Mar 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $11 | $3.00 | n/a | 3 | Dec 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 | $48.77 | n/a | 10 | Nov 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $3.5 | $7.81 | n/a | 4 | Nov 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $10 → $1 | $0.0111 | n/a | 19 | Oct 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 → $7.5 | $29.50 | n/a | 19 | Aug 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $26 | $0.0001 | n/a | 3 | Jun 18, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $10.45 | n/a | 1 | Jun 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $126.23 | n/a | 1 | Mar 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $155 | $517.49 | n/a | 1 | Jul 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $4.75 | n/a | 1 | Jun 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $0.9665 | n/a | 7 | Jun 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 | $0.5133 | n/a | 9 | May 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 → $15 | $23.54 | n/a | 10 | Mar 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $6 → $8.75 | $9.91 | n/a | 7 | Jan 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.5 | $10.00 | n/a | 7 | Jan 12, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $0.0001 | n/a | 1 | Mar 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $11 | $35.77 | n/a | 7 | Mar 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $0.8043 | n/a | 1 | Feb 22, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $6 → $7 | $1.07 | n/a | 6 | Oct 30, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 | $0.1831 | n/a | 1 | Aug 22, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $37.45 | n/a | 7 | May 15, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $6 → $4 | $65.11 | n/a | 2 | May 2, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $158.69 | n/a | 1 | Jan 27, 2010 |
BridgeBio Oncology Therapeutics
Oct 26, 2026
Reiterated: Buy
Price Target: $21
Current: $2.64
Upside: +695.45%
Crescent Biopharma
Oct 26, 2026
Reiterated: Buy
Price Target: $35
Current: $12.76
Upside: +174.29%
Compass Therapeutics
Oct 26, 2026
Reiterated: Buy
Price Target: $6
Current: $0.7472
Upside: +703.00%
Aclaris Therapeutics
Oct 19, 2026
Reiterated: Buy
Price Target: $11
Current: $3.79
Upside: +190.24%
BridgeBio Pharma
Oct 19, 2026
Reiterated: Buy
Price Target: $115 → $120
Current: $68.15
Upside: +76.08%
LENZ Therapeutics
Oct 19, 2026
Reiterated: Hold
Price Target: $7 → $5
Current: $3.15
Upside: +58.98%
Regeneron Pharmaceuticals
Oct 19, 2026
Reiterated: Buy
Price Target: $854 → $865
Current: $807.67
Upside: +7.10%
Sarepta Therapeutics
Oct 19, 2026
Reiterated: Hold
Price Target: $20
Current: $17.98
Upside: +11.23%
Opus Genetics
Oct 16, 2026
Reiterated: Buy
Price Target: $11
Current: $3.32
Upside: +231.33%
Taysha Gene Therapies
Oct 16, 2026
Reiterated: Buy
Price Target: $12
Current: $4.01
Upside: +199.25%
Oct 13, 2026
Rated: Buy
Price Target: $35
Current: $25.55
Upside: +36.99%
Oct 12, 2026
Reiterated: Buy
Price Target: $31
Current: $6.47
Upside: +379.13%
Sep 30, 2026
Reiterated: Buy
Price Target: $18
Current: $5.81
Upside: +209.81%
Sep 28, 2026
Reiterated: Buy
Price Target: $101 → $123
Current: $70.54
Upside: +74.37%
Sep 23, 2026
Reiterated: Buy
Price Target: $140
Current: $114.84
Upside: +21.91%
Aug 27, 2026
Reiterated: Buy
Price Target: $7
Current: $1.44
Upside: +386.11%
Aug 13, 2026
Reiterated: Buy
Price Target: $10
Current: $1.21
Upside: +726.45%
Aug 13, 2026
Reiterated: Buy
Price Target: $7
Current: $0.8489
Upside: +724.60%
Aug 12, 2026
Reiterated: Buy
Price Target: $33
Current: $17.89
Upside: +84.46%
Aug 12, 2026
Initiated Coverage: Buy
Price Target: $2
Current: $0.5054
Upside: +295.73%
Aug 11, 2026
Rated: Buy
Price Target: $16 → $14
Current: $1.21
Upside: +1,057.02%
Jul 30, 2026
Reiterated: Buy
Price Target: $71
Current: $24.21
Upside: +193.27%
Jun 2, 2026
Reiterated: Buy
Price Target: $7
Current: $0.2399
Upside: +2,817.88%
Jun 1, 2026
Reiterated: Buy
Price Target: $48
Current: $15.45
Upside: +210.68%
Mar 30, 2026
Reiterated: Hold
Price Target: $5 → $7
Current: $1.80
Upside: +288.89%
Oct 20, 2025
Reiterated: Buy
Price Target: $35 → $51
Current: $3.99
Upside: n/a
Mar 21, 2025
Downgraded: Hold
Price Target: $10 → $0.7
Current: -
Upside: n/a
May 19, 2023
Reiterated: Buy
Price Target: $63 → $70
Current: $2.07
Upside: n/a
Mar 3, 2022
Downgraded: Hold
Price Target: $142 → $94
Current: $145.87
Upside: n/a
Aug 24, 2021
Reiterated: Buy
Price Target: $56
Current: $20.39
Upside: n/a
Jul 23, 2021
Reiterated: Buy
Price Target: $25
Current: $0.3007
Upside: n/a
Mar 17, 2021
Reiterated: Buy
Price Target: $14 → $19
Current: $7.15
Upside: n/a
Mar 15, 2021
Rated: Buy
Price Target: $8 → $7
Current: $6.16
Upside: n/a
Mar 12, 2021
Reiterated: Buy
Price Target: $34 → $51
Current: $2.98
Upside: n/a
Feb 10, 2021
Reiterated: Buy
Price Target: $21
Current: $1.25
Upside: n/a
Jan 15, 2021
Reiterated: Buy
Price Target: $27 → $32
Current: $3.65
Upside: n/a
Dec 21, 2020
Reiterated: Buy
Price Target: $39 → $109
Current: $2.06
Upside: n/a
Dec 21, 2020
Reiterated: Buy
Price Target: $43 → $60
Current: $13.78
Upside: n/a
Dec 9, 2020
Downgraded: Hold
Price Target: n/a
Current: $1.53
Upside: n/a
Sep 14, 2020
Downgraded: Hold
Price Target: $15 → $10
Current: $0.1862
Upside: n/a
Aug 7, 2020
Reiterated: Hold
Price Target: $10 → $9
Current: $2.23
Upside: n/a
Jul 29, 2020
Reiterated: Hold
Price Target: $36 → $18
Current: $44.44
Upside: n/a
Jul 7, 2020
Initiated Coverage: Buy
Price Target: $41
Current: $59.97
Upside: n/a
May 29, 2020
Downgraded: Hold
Price Target: $18 → $2
Current: $2.20
Upside: n/a
Mar 27, 2020
Initiated Coverage: Buy
Price Target: $6
Current: $0.0003
Upside: n/a
Dec 3, 2019
Reiterated: Buy
Price Target: $6 → $11
Current: $3.00
Upside: n/a
Nov 8, 2019
Downgraded: Hold
Price Target: $12
Current: $48.77
Upside: n/a
Nov 12, 2018
Reiterated: Hold
Price Target: $4 → $3.5
Current: $7.81
Upside: n/a
Oct 10, 2018
Downgraded: Hold
Price Target: $10 → $1
Current: $0.0111
Upside: n/a
Aug 10, 2018
Reiterated: Hold
Price Target: $15 → $7.5
Current: $29.50
Upside: n/a
Jun 18, 2018
Reiterated: Buy
Price Target: $21 → $26
Current: $0.0001
Upside: n/a
Jun 5, 2018
Initiated Coverage: Buy
Price Target: $17
Current: $10.45
Upside: n/a
Mar 19, 2018
Initiated Coverage: Buy
Price Target: $12
Current: $126.23
Upside: n/a
Jul 11, 2017
Initiated Coverage: Buy
Price Target: $155
Current: $517.49
Upside: n/a
Jun 22, 2017
Reiterated: Buy
Price Target: $17
Current: $4.75
Upside: n/a
Jun 6, 2017
Reiterated: Buy
Price Target: $47
Current: $0.9665
Upside: n/a
May 15, 2017
Reiterated: Hold
Price Target: $3
Current: $0.5133
Upside: n/a
Mar 10, 2017
Reiterated: Hold
Price Target: $9 → $15
Current: $23.54
Upside: n/a
Jan 18, 2017
Downgraded: Hold
Price Target: $6 → $8.75
Current: $9.91
Upside: n/a
Jan 12, 2017
Reiterated: Hold
Price Target: $1.5
Current: $10.00
Upside: n/a
Mar 9, 2016
Reiterated: Buy
Price Target: $9
Current: $0.0001
Upside: n/a
Mar 9, 2016
Reiterated: Buy
Price Target: $12 → $11
Current: $35.77
Upside: n/a
Feb 22, 2016
Reiterated: Buy
Price Target: $15
Current: $0.8043
Upside: n/a
Oct 30, 2015
Rated: Buy
Price Target: $6 → $7
Current: $1.07
Upside: n/a
Aug 22, 2014
Downgraded: Hold
Price Target: $5
Current: $0.1831
Upside: n/a
May 15, 2014
Initiated Coverage: Buy
Price Target: $15
Current: $37.45
Upside: n/a
May 2, 2014
Rated: Hold
Price Target: $6 → $4
Current: $65.11
Upside: n/a
Jan 27, 2010
Reiterated: Buy
Price Target: $29
Current: $158.69
Upside: n/a